ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma Meeting Abstract
| Authors: | Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; Moskowitz, C. H.; Beumer, J. H.; Chen, A.; Little, R. F.; France, F.; Whang, J.; Winkelman, J.; Stasi, M.; Russell, C.; Cazeau, N.; Kargus, K.; Zelenetz, A. D. |
| Abstract Title: | ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000435860200024 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.4366.4366 |
| Notes: | Meeting Abstract: 4366 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
